Ducommun (DCO), a key supplier of components and assemblies for aerospace, defense, and industrial sectors, is approaching its Q1 2026 earnings with solid momentum from a record-breaking 2025. Full-year revenue came in at $824.7 million, up 4.9%, even after a $107.3 million litigation charge affected net income. Adjusted EBITDA hit a record $135.6 million, or 16.4% of revenue, which underscores their strong margin discipline. In my view, this report is particularly important as it will offer visibility into defense production ramps aligned with U.S. Department of Defense priorities and any initial signs of relief from commercial aerospace destocking. With shares up notably year-to-date on backlog strength, investors are eager for confirmation of ongoing growth in this volatile sector.
Wall Street's average call from five analysts points to Q1 2026 revenue of $199.8 million, marking modest growth both sequentially from Q4 2025's $215.8 million and year-over-year from Q1 2025's $194.1 million. The EPS consensus ranges from $0.72 (Zacks) to $0.82 (MarketBeat), a slight dip from Q1 2025's adjusted $0.83 but in line with typical seasonal patterns for the sector.
Ducommun has a strong track record, beating EPS estimates over the last eight quarters with average surprises of 15-20%—Q4 2025 saw $1.05 actual versus $0.91 expected, for instance. Key areas to monitor include RPO conversion, gross margins (27.7% in Q4), and adjusted EBITDA margins. Management didn't provide formal Q1 guidance after Q4, but they emphasized strength in missile programs through long-term agreements (LTAs) with RTX and Lockheed Martin, helping offset commercial challenges. I also checked DCO against industry peers using Tickeron’s AI Screener to gauge its relative positioning.
One tool I rely on regularly for digging deeper into stocks like DCO is Tickeron’s AI Screener. This AI-powered stock and ETF discovery platform lets me filter thousands of assets using customizable criteria like technical patterns, fundamentals, trends, volatility, and AI signals—think industry filters, market cap, indicators, price patterns, and performance metrics. It surfaces trade ideas, breakout candidates, and market opportunities far more efficiently than manual scans, streamlining my research process. If you're screening for similar setups in aerospace and defense, it's a solid addition to your toolkit.
As we head into Q1 earnings expected on May 5, 2026, sentiment toward DCO remains cautiously optimistic, supported by the $1.1 billion RPO and favorable defense trends. The stock has responded well to prior beats, including gains after Q4 2025 despite a minor revenue shortfall. Potential risks involve commercial aerospace delays and tariff impacts, though management views them as immaterial. Implied volatility indicates a possible 10-12% move post-earnings, which is standard for the sector.
Post-Q1, the focus will shift to any full-year 2026 guidance, leveraging 2025's strong results. Management anticipates ramps in missile production and defense spending to boost military/space revenue, backed by LTAs and DoD priorities.
Progress in commercial aerospace will depend on Boeing's production increases and destocking normalization, which could pick up in H2 2026. One thing I'll be tracking closely is RPO evolution from $1.106 billion, book-to-bill ratios (1.3x in Q4), and margin progress toward the VISION 2027 goal of 18% adjusted EBITDA.
Additional drivers include growth in engineered products (23% of 2025 revenue, up from 15% in 2022) and tariff strategies like exemptions or pass-throughs. Broader tailwinds from steady defense budgets persist, while supply chain steadiness will affect efficiency. From what I see, these elements position DCO well for continued execution.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
The 10-day RSI Oscillator for DCO moved out of overbought territory on August 07, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DCO as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for DCO turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DCO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
DCO broke above its upper Bollinger Band on August 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DCO advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 324 cases where DCO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DCO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.191) is normal, around the industry mean (7.037). P/E Ratio (34.664) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (3.353) is also within normal values, averaging (20.174).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of aircraft components and equipment
Industry AerospaceDefense